New Diagnosed Angioimmunoblastic T-Cell Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which New Diagnosed Angioimmunoblastic T-Cell Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07168317

Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of New Diagnosed AIT…

Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive lymphoma. At present, the treatment of new diagnosed AITL has limited efficacy and a high rec…

China40 participantsStarted 2025-08-01

Treatment: tislelizumab in combination with cyclophosphamide, mitoxantrone liposomes, chidamide, and prednisone

All recent trials (2 shown)

UnknownPhase 4

NCT01746992

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

T cell lymphoma is a heterogenic malignancy with poor outcome. Five-year PFS and OS of the patients recieved classic CHOP regimen(cyclophosphamide,vincristin,do…

China200 participantsStarted 2012-09

Treatment: Cyclophosphamide 750mg/m2, Vincristine 1.4mg/m2